Pharmaceutical Companies in France: Sourcing and Due Diligence from Official Data

April 14, 2026 · OneFirmIntel

France is home to some of Europe's most significant pharmaceutical manufacturers, from global innovators headquartered in Paris to contract development and manufacturing organisations clustered around Lyon and Strasbourg. Yet the French company register, le Registre du Commerce et des Sociétés, holds almost 30 million entities in total, the vast majority of which have nothing to do with life sciences. Quality grading is the tool that makes the register actionable.

Distribution of all 29.6 M French registered entities across OneFirmIntel quality tiers (2026). · Source: OneFirmIntel dataset

France's Pharmaceutical Landscape at a Glance

France consistently ranks among the top five European pharmaceutical markets by production value. The sector includes large integrated groups with global distribution, a dense network of generic manufacturers, a growing biosimilars cohort, and hundreds of contract research organisations that support clinical-trial activity across the EU. This diversity makes France an attractive sourcing destination, and a complex one.

The French registry distinguishes between SAS, SARL, SA, and SNC legal forms, each carrying different governance and disclosure obligations. For pharmaceutical procurement, SA (Société Anonyme) entities are most common among mid-to-large manufacturers, and they carry the most robust public filing requirements. Understanding legal form alongside tier grade gives buyers a more complete picture of counterparty risk.

Reading the French Register Through Quality Tiers

Of the 29,572,772 French entities in OneFirmIntel, 37,834 are ★★★ Listed, a notably higher share than in the US, reflecting France's tradition of listed SMEs on Euronext Growth. The 13,763,511 Established (★★) entities represent the backbone of the professional business community, including the majority of serious pharmaceutical producers and distributors. The 3,198,239 Active (★) entities are registered and in good standing but have thinner filing histories.

For pharmaceutical sourcing specifically, the Listed tier is worth prioritising for large-volume API procurement because it includes companies subject to AMF (Autorité des Marchés Financiers) disclosure rules, providing financials in the public domain. For speciality ingredients, contract filling, or secondary packaging, the Established tier is usually the most productive filter to apply first.

Key Due Diligence Signals for French Pharma Suppliers

Several registry signals are particularly informative for pharmaceutical sector evaluation. First, the APE (Activité Principale Exercée) code: APE 2110Z covers basic pharmaceutical manufacturing; 2120Z covers pharmaceutical preparations. A supplier whose APE code does not align with their claimed capabilities is a red flag that warrants explanation before proceeding to qualification.

Second, capital social (registered share capital) is a proxy for financial substance. A contract manufacturer with €1,000 registered capital has a very different risk profile from one with €2 million, even if both describe themselves similarly on a trade website. Third, check for recent SIREN/SIRET changes, a new SIRET on a long-established SIREN can indicate a restructuring that your compliance team should review.

Navigating DUNS, SIREN, and Company Number Mapping

One operational challenge when managing a French supplier panel is identifier proliferation. French companies have a SIREN (9 digits, national business ID), one or more SIRET numbers (14 digits, establishment-level), and potentially a D-U-N-S number used in international trade finance. OneFirmIntel anchors its records on the official SIREN, which is the stable, deduplicated identifier for corporate-level due diligence.

Using SIREN as your master identifier in ERP and supplier-management systems prevents the duplication that occurs when the same company appears under multiple trading names or subsidiary SIRET codes. This is especially important in pharmaceutical supply chains where traceability to the licensed legal entity is a regulatory requirement under EU GMP guidelines.

Business Development: Finding Distribution and Licensing Partners

For companies seeking French pharmaceutical distribution partners or in-licensing opportunities, the registry data supports outreach list building in a way that trade directories cannot. By filtering for Established (★★) or Listed (★★★) entities with APE codes in the 46.46Z (wholesale of pharmaceutical goods) range and incorporation dates before 2010, you generate a list of tenured distributors with verifiable market presence.

This approach is more defensible than sourcing contact lists from commercial databases that aggregate LinkedIn profiles or web-scraped data, because every entry traces back to an official government filing. For regulated industries like pharmaceuticals, that provenance matters both for internal compliance sign-off and for demonstrating third-party vetting rigour to auditors.

Practical Steps for Using the France Directory

Begin on the OneFirmIntel France directory by applying tier and industry filters to narrow the 29.6 million entities to a workable long-list of pharmaceutical candidates. Use the incorporation-year filter to apply your minimum-tenure threshold. Download the filtered list in CSV format and import it into your supplier-qualification template alongside the official SIREN numbers.

For each shortlisted entity, the platform surfaces the tier grade, registered legal form, incorporation date, and city, enough to decide whether to proceed to the more resource-intensive steps of requesting financials, visiting facilities, or commissioning a full third-party audit. This triage approach can cut early-stage qualification time by a significant margin compared with manual registry look-ups.

Sources & further reading

External links are provided for reference; third-party names are trademarks of their owners.

See the data

Explore the companies behind these numbers.

Browse the France Directory →

FAQ

How many pharmaceutical companies are registered in France?

The live count for French pharmaceutical entities is available on the /directory/france/pharmaceuticals page. France holds 29,572,772 total registered entities across all sectors in OneFirmIntel.

What is the difference between SIREN and SIRET for supplier management?

SIREN (9 digits) identifies the legal entity at national level, the correct level for corporate due diligence. SIRET (14 digits) identifies individual establishments of that entity. OneFirmIntel uses SIREN as the master identifier.

Which quality tier should I filter for when sourcing pharmaceutical contract manufacturers in France?

Start with ★★★ Listed and ★★ Established tiers. Listed entities are subject to AMF disclosure requirements; Established entities have demonstrable filing depth. Both provide a significantly stronger due-diligence baseline than ★ Active alone.

Is French registry data updated in real time on OneFirmIntel?

OneFirmIntel refreshes French RCS data on a regular cycle. The date of last update is shown on each company profile. For time-sensitive compliance checks, always cross-verify against the INPI (Institut National de la Propriété Industrielle) official portal.